RU2018128415A3 - - Google Patents

Download PDF

Info

Publication number
RU2018128415A3
RU2018128415A3 RU2018128415A RU2018128415A RU2018128415A3 RU 2018128415 A3 RU2018128415 A3 RU 2018128415A3 RU 2018128415 A RU2018128415 A RU 2018128415A RU 2018128415 A RU2018128415 A RU 2018128415A RU 2018128415 A3 RU2018128415 A3 RU 2018128415A3
Authority
RU
Russia
Application number
RU2018128415A
Other languages
Russian (ru)
Other versions
RU2761824C2 (ru
RU2018128415A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to RU2018128415A priority Critical patent/RU2761824C2/ru
Application filed filed Critical
Priority to MX2021001335A priority patent/MX2021001335A/es
Priority to US17/264,670 priority patent/US11840531B2/en
Priority to MA52375A priority patent/MA52375B2/fr
Priority to PE2021000162A priority patent/PE20210416A1/es
Priority to CA3108298A priority patent/CA3108298A1/en
Priority to BR112021001939-1A priority patent/BR112021001939A2/pt
Priority to AU2019313199A priority patent/AU2019313199B2/en
Priority to KR1020217006527A priority patent/KR102926889B1/ko
Priority to JP2021505964A priority patent/JP7365396B2/ja
Priority to CN201980065665.1A priority patent/CN113166140B/zh
Priority to EA202190452A priority patent/EA202190452A1/ru
Priority to PCT/RU2019/050123 priority patent/WO2020027704A1/ru
Priority to EP19844331.9A priority patent/EP3831829A4/en
Priority to ARP190102200A priority patent/AR115898A1/es
Priority to TW108127569A priority patent/TWI839374B/zh
Publication of RU2018128415A publication Critical patent/RU2018128415A/ru
Priority to CL2021000282A priority patent/CL2021000282A1/es
Priority to CONC2021/0001174A priority patent/CO2021001174A2/es
Priority to PH12021550258A priority patent/PH12021550258A1/en
Publication of RU2018128415A3 publication Critical patent/RU2018128415A3/ru
Application granted granted Critical
Publication of RU2761824C2 publication Critical patent/RU2761824C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2018128415A 2018-08-03 2018-08-03 Ингибиторы CDK8/19 RU2761824C2 (ru)

Priority Applications (19)

Application Number Priority Date Filing Date Title
RU2018128415A RU2761824C2 (ru) 2018-08-03 2018-08-03 Ингибиторы CDK8/19
EA202190452A EA202190452A1 (ru) 2018-08-03 2019-07-31 Ингибиторы cdk8/19
MA52375A MA52375B2 (fr) 2018-08-03 2019-07-31 Inhibiteurs de cdk8/19
PE2021000162A PE20210416A1 (es) 2018-08-03 2019-07-31 Inhibidores de ckd8/19
CA3108298A CA3108298A1 (en) 2018-08-03 2019-07-31 Cdk8/19 inhibitors
BR112021001939-1A BR112021001939A2 (pt) 2018-08-03 2019-07-31 inibidores de cdk8/19
AU2019313199A AU2019313199B2 (en) 2018-08-03 2019-07-31 CDK8/19 inhibitors
KR1020217006527A KR102926889B1 (ko) 2018-08-03 2019-07-31 Cdk8/19 저해제
JP2021505964A JP7365396B2 (ja) 2018-08-03 2019-07-31 Cdk8/19阻害薬
EP19844331.9A EP3831829A4 (en) 2018-08-03 2019-07-31 CDK8/19 INHIBITORS
MX2021001335A MX2021001335A (es) 2018-08-03 2019-07-31 Inhibidores de ckd8/19.
US17/264,670 US11840531B2 (en) 2018-08-03 2019-07-31 CDK8/19 inhibitors
CN201980065665.1A CN113166140B (zh) 2018-08-03 2019-07-31 Cdk8/19抑制剂
PCT/RU2019/050123 WO2020027704A1 (ru) 2018-08-03 2019-07-31 Ингибиторы cdk8/19
ARP190102200A AR115898A1 (es) 2018-08-03 2019-08-02 1,7-naftiridinas como inhibidores de cdk8/19
TW108127569A TWI839374B (zh) 2018-08-03 2019-08-02 Cdk8/19抑制劑
CL2021000282A CL2021000282A1 (es) 2018-08-03 2021-02-02 Inhibidores de ckd8/19
CONC2021/0001174A CO2021001174A2 (es) 2018-08-03 2021-02-02 Inhibidores de ckd8/19
PH12021550258A PH12021550258A1 (en) 2018-08-03 2021-02-03 Cdk8/19 inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2018128415A RU2761824C2 (ru) 2018-08-03 2018-08-03 Ингибиторы CDK8/19

Publications (3)

Publication Number Publication Date
RU2018128415A RU2018128415A (ru) 2020-02-04
RU2018128415A3 true RU2018128415A3 (cg-RX-API-DMAC7.html) 2021-03-30
RU2761824C2 RU2761824C2 (ru) 2021-12-13

Family

ID=69231230

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018128415A RU2761824C2 (ru) 2018-08-03 2018-08-03 Ингибиторы CDK8/19

Country Status (19)

Country Link
US (1) US11840531B2 (cg-RX-API-DMAC7.html)
EP (1) EP3831829A4 (cg-RX-API-DMAC7.html)
JP (1) JP7365396B2 (cg-RX-API-DMAC7.html)
KR (1) KR102926889B1 (cg-RX-API-DMAC7.html)
CN (1) CN113166140B (cg-RX-API-DMAC7.html)
AR (1) AR115898A1 (cg-RX-API-DMAC7.html)
AU (1) AU2019313199B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021001939A2 (cg-RX-API-DMAC7.html)
CA (1) CA3108298A1 (cg-RX-API-DMAC7.html)
CL (1) CL2021000282A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021001174A2 (cg-RX-API-DMAC7.html)
EA (1) EA202190452A1 (cg-RX-API-DMAC7.html)
MA (1) MA52375B2 (cg-RX-API-DMAC7.html)
MX (1) MX2021001335A (cg-RX-API-DMAC7.html)
PE (1) PE20210416A1 (cg-RX-API-DMAC7.html)
PH (1) PH12021550258A1 (cg-RX-API-DMAC7.html)
RU (1) RU2761824C2 (cg-RX-API-DMAC7.html)
TW (1) TWI839374B (cg-RX-API-DMAC7.html)
WO (1) WO2020027704A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4178955A1 (en) 2020-07-11 2023-05-17 Pfizer Inc. Antiviral heteroaryl ketone derivatives
US11351149B2 (en) 2020-09-03 2022-06-07 Pfizer Inc. Nitrile-containing antiviral compounds
CA3251059A1 (en) 2022-05-02 2023-11-09 The Board Of Trustees Of The Leland Stanford Junior University Compositions, systems and methods for modulating a target gene
WO2024109660A1 (zh) * 2022-11-21 2024-05-30 上海齐鲁制药研究中心有限公司 Cdk抑制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200808739A (en) 2006-04-06 2008-02-16 Novartis Vaccines & Diagnostic Quinazolines for PDK1 inhibition
EP2229375A1 (en) 2007-12-06 2010-09-22 Schering Corporation Gamma secretase modulators
EP2630122B1 (en) * 2010-10-18 2016-11-30 RaQualia Pharma Inc Arylamide derivatives as ttx-s blockers
TWI529171B (zh) * 2013-07-29 2016-04-11 赫孚孟拉羅股份公司 1,7-萘啶衍生物
JP2017522324A (ja) 2014-07-17 2017-08-10 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung 新規ナフチリジン及びイソキノリンならびにcdk8/19阻害剤としてのその使用
EP3383875B1 (en) * 2015-11-30 2022-02-09 Council Of Scientific & Industrial Research 3-pyrimidinyl pyrrolo [2,3-b] pyridine as anticancer agents and the process for the preparation thereof
EP3464267B1 (en) * 2016-05-23 2020-09-23 Boehringer Ingelheim International GmbH New phenylpyrazolylacetamide compounds and derivatives as cdk8/cdk19 inhibitors

Also Published As

Publication number Publication date
KR102926889B1 (ko) 2026-02-19
CN113166140A (zh) 2021-07-23
AR115898A1 (es) 2021-03-10
MA52375B2 (fr) 2023-02-28
US11840531B2 (en) 2023-12-12
CL2021000282A1 (es) 2021-08-13
PH12021550258A1 (en) 2021-10-11
JP2021533143A (ja) 2021-12-02
CA3108298A1 (en) 2020-02-06
AU2019313199A1 (en) 2021-03-11
BR112021001939A2 (pt) 2021-04-27
WO2020027704A1 (ru) 2020-02-06
CO2021001174A2 (es) 2021-02-26
KR20210040416A (ko) 2021-04-13
CN113166140B (zh) 2024-06-14
RU2761824C2 (ru) 2021-12-13
EP3831829A1 (en) 2021-06-09
AU2019313199B2 (en) 2023-07-06
US20210246138A1 (en) 2021-08-12
PE20210416A1 (es) 2021-03-04
TW202012406A (zh) 2020-04-01
EP3831829A4 (en) 2022-04-20
TWI839374B (zh) 2024-04-21
EA202190452A1 (ru) 2021-04-13
RU2018128415A (ru) 2020-02-04
JP7365396B2 (ja) 2023-10-19
MX2021001335A (es) 2021-04-12
MA52375A1 (fr) 2021-12-31

Similar Documents

Publication Publication Date Title
BR112021000792B8 (cg-RX-API-DMAC7.html)
AT524874A5 (cg-RX-API-DMAC7.html)
AT524834A2 (cg-RX-API-DMAC7.html)
AT521543A3 (cg-RX-API-DMAC7.html)
AT524961A5 (cg-RX-API-DMAC7.html)
AT524266A2 (cg-RX-API-DMAC7.html)
BR102019026286B1 (pt) Método e aparelho para o avanço de produtos a serem moldados
BR102019025884B1 (pt) Sistema de segurança aprimorado para máquinas de operação de autopropulsão
BR102019023514B1 (pt) Método para determinar a massa de ar preso em cada cilindro de um motor a combustão interna
BR112020016338B1 (pt) Dispositivo para tratamento de tecido corporal
BR112021001434B1 (pt) Aço com alto teor de manganês e método de produção do mesmo
BR112021001374B1 (pt) Composição farmacêutica para o tratamento da hipertensão e seu uso
BR112021001128B1 (pt) Composição de cimento para impressão 3d, método de impressão 3d, kit para a preparação de uma composição de cimento para impressão 3d e método de impressão 3d implementando o kit
BR112021000922B1 (pt) Tela de filtro, e, método para purificar água de alimentação
BR112020026077B1 (pt) Recipiente com estrutura encaixável
BR112020026721B1 (pt) Aparelho de moldagem para modar uma folha de um material contendo alcaloides
BR102019012845B1 (pt) Montagens de guia de entrada de piso de compartimento de carga retráteis para carregamentos paletizados em aeronaves de carga e aeronave e carga
BR112020023832B1 (pt) Amostra de calibração de sistemas de análise multiespectral e método para calibração de sistemas de análise multiespectral
BR112020022482B1 (pt) Composição, anticorpo anti-cd24, anticorpo biespecífico e receptor de antígeno quimérico
BR112020022658B1 (pt) Método para estimar um nível de pressão sonora, sistema de fone de ouvido, fone de ouvido e uso do fone de ouvido
BR112020021042B1 (pt) Compostos de carboxamidas bicíclicas, composição farmacêutica e uso das mesmas
BR112020020812B1 (pt) Composições de tratamento de superfícies duras, seu uso, método para proporcionar ação antimicrobiana residual e substrato relacionado
BR112020015757B1 (pt) Métodos, sistema, kit e dispositivos para visualização e remoção de tumor
BR102019000241B1 (pt) Veículo modular, configurável, sobre plataforma de chassis comum, e métodos e sistemas associados
BR102018073077B1 (pt) Processo de extração de gelatina de resíduos de couro curtido ao cromo wet blue